Anticorps Recombinant de lapin anti-CD82
CD82 Recombinant Antibody for IF/ICC, Indirect ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
IF/ICC, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
241765E10
N° de cat : 84617-3-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
84617-3-PBS cible CD82 dans les applications de IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Lapin / IgG |
Clonalité | Recombinant |
Type | Anticorps |
Immunogène | CD82 Protéine recombinante Eg1749 |
Nom complet | CD82 molecule |
Masse moléculaire calculée | 30 kDa |
Numéro d’acquisition GenBank | NM_002231.4 |
Symbole du gène | CD82 |
Identification du gène (NCBI) | 3732 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par protéine A |
Tampon de stockage | PBS only |
Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
CD82 is a membrane glycoprotein and belongs to the tetraspanin superfamily, many of which are implicated in the regulation of cell motility, morphology, fusion, signaling, fertilization, and differentiation. CD82 was originally identified as a suppressor of metastasis located on human chromosome 11p11.2 in prostate carcinoma. The majority of evidence indicates that CD82 expression is downregulated or abolished in a variety of malignant tumors. CD82 is present at high levels in human monocyte and macrophage lineages and in various epithelial cells in the prostate, lung, pancreas and many other tissues. In epithelial cells, CD82 is implicated in diverse biological processes such as cell adhesion, migration, apoptosis and morphogenesis.